| WKN: | A1EWVY |
| ISIN: | DE000A1EWVY8 |
| Land: | Deutschland |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Formycon-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 10. Dezember 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 2,99 | 7,53 | 151,67% |
| 2 | 2015 | 9,80 | 23,16 | 136,28% |
| 3 | 2020 | 31,00 | 53,60 | 72,90% |
| 4 | 2022 | 58,00 | 85,80 | 47,93% |
| 5 | 2017 | 23,78 | 32,20 | 35,40% |
| 6 | 2014 | 7,53 | 9,80 | 30,15% |
| 7 | 2019 | 26,00 | 31,00 | 19,23% |
| 8 | 2021 | 53,60 | 58,00 | 8,21% |
| 9 | 2016 | 23,16 | 23,78 | 2,71% |
| 10 | 2024 | 55,50 | 51,60 | -7,03% |
| 11 | 2018 | 32,20 | 26,00 | -19,25% |
| 12 | 2011 | 9,66 | 6,34 | -34,36% |
| 13 | 2023 | 85,80 | 55,50 | -35,31% |
| 14 | 2012 | 6,34 | 2,99 | -52,79% |
| 15 | 2025 | 51,60 | 24,10 | -53,29% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2025 | 51,60 | 24,10 | -53,29% |
| 2 | 2012 | 6,34 | 2,99 | -52,79% |
| 3 | 2023 | 85,80 | 55,50 | -35,31% |
| 4 | 2011 | 9,66 | 6,34 | -34,36% |
| 5 | 2018 | 32,20 | 26,00 | -19,25% |
| 6 | 2024 | 55,50 | 51,60 | -7,03% |
| 7 | 2016 | 23,16 | 23,78 | 2,71% |
| 8 | 2021 | 53,60 | 58,00 | 8,21% |
| 9 | 2019 | 26,00 | 31,00 | 19,23% |
| 10 | 2014 | 7,53 | 9,80 | 30,15% |
| 11 | 2017 | 23,78 | 32,20 | 35,40% |
| 12 | 2022 | 58,00 | 85,80 | 47,93% |
| 13 | 2020 | 31,00 | 53,60 | 72,90% |
| 14 | 2015 | 9,80 | 23,16 | 136,28% |
| 15 | 2013 | 2,99 | 7,53 | 151,67% |